| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $93,525,715 ) (Continued on the next page) |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | TL1TR002016 | J: Penn State NRSA Training Core | 000 | 9 | NIH | 8/5/2025 | $354,250 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | TL1TR002016 | J: Penn State NRSA Training Core | 001 | 9 | NIH | 9/16/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | KL2TR002015 | I: Penn State Institutional Career Development Core | 000 | 9 | NIH | 8/5/2025 | $553,607 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | UL1TR002014 | Penn State Clinical and Translational Science Institute | 000 | 9 | NIH | 8/5/2025 | $3,795,402 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS091299 | Translation dysregulation in neurodegeneration | 000 | 8 | NIH | 6/6/2025 | $707,634 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01ES026184 | The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance | 000 | 9 | NIH | 1/6/2025 | $379,533 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01ES026184 | The Role of Mono-ADP-Ribosylation by PARP14 in Radioresistance | 001 | 9 | NIH | 1/28/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS126448 | Using cryo-electron tomography and live-cell fluorescent imaging to study the role of cofilin in regulating neuronal filopodial structure and dynamics | 000 | 3 | NIH | 1/17/2025 | $357,869 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS136371 | Neuroanatomy and function of the ventral claustrum-dorsal endopiriform nucleus in mice | 000 | 1 | NIH | 1/24/2025 | $525,912 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL170140 | Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension | 001 | 2 | NIH | 7/24/2025 | $71,970 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL170140 | Angiotensin-(1-7) and Cardiovascular Derangements in Obesity Hypertension | 000 | 2 | NIH | 3/28/2025 | $647,738 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA222349 | Non-canonical Caspase-8 Activation on Autophagosomal Membranes | 003 | 7 | NIH | 5/21/2025 | $41,850 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA222349 | Non-canonical Caspase-8 Activation on Autophagosomal Membranes | 002 | 7 | NIH | 1/27/2025 | $376,650 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | RM1MH138309 | Cross Scale Interrogation of NPD Genes (SING) in mice | 000 | 1 | NIH | 1/14/2025 | $3,498,931 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS115942 | Poly-omic predictors of symptom duration and recovery for adolescent concussion | 001 | 5 | NIH | 3/13/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS115942 | Poly-omic predictors of symptom duration and recovery for adolescent concussion | 000 | 5 | NIH | 12/24/2024 | $268,092 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL173039 | SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy | 001 | 1 | NIH | 1/27/2025 | $9,454 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL173039 | SHePREG: Study of Heart function in PRE-Eclampsia during and after PreGnancy | 000 | 1 | NIH | 1/14/2025 | $1,274,927 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA260901 | Early clinial trials for Angelica herbal supplements for prostate cancer interception | 001 | 4 | NIH | 9/8/2025 | $1,175,356 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS119538 | Novel Targets and Therapeutic Interventions against Cerebral Ischemia-Reperfusion Injury | 000 | 5 | NIH | 5/30/2025 | $601,657 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K08HL159314 | Abnormal Bleeding Risk in Female Hemophilia A Carriers | 000 | 5 | NIH | 8/14/2025 | $172,670 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R21CA290500 | Stories to Prevent (StoP) HPV Cancers: A communication intervention to increase HPV vaccination among diverse populations | 000 | 1 | NIH | 3/25/2025 | $233,411 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01AI130156 | Analysis of the mechanism of HCMV cytoplasmic envelopment | 002 | 8 | NIH | 1/8/2025 | $472,949 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS139128 | Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP | 000 | 2 | NIH | 7/10/2025 | $650,715 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01NS139128 | Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP | 000 | 2 | NIH | 7/10/2025 | $167,794 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35GM147238 | Deciphering the progression and regulation of human translesion DNA synthesis | 000 | 4 | NIH | 5/1/2025 | $394,265 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K23DK131290 | Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis | 001 | 4 | NIH | 6/23/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | K23DK131290 | Establishing the mechanism of benefit and dose of exercise required to improve liver histology in patients with nonalcoholic steatohepatitis | 000 | 4 | NIH | 11/22/2024 | $200,135 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | UH3HL161342 | 1/2 Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial | 001 | 3 | NIH | 9/19/2025 | $262,705 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01DK130992 | Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals | 001 | 4 | NIH | 2/17/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01DK130992 | Glucose Management Clinical Decision Support to Improve Outcomes in Academic and Community Hospitals | 000 | 4 | NIH | 11/22/2024 | $579,218 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01GM127954 | Autophagosome closure by the ESCRT machinery | 000 | 8 | NIH | 8/1/2025 | $347,987 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 001 | 3 | NIH | 11/25/2024 | $92,718 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 000 | 3 | NIH | 11/21/2024 | $614,075 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 003 | 3 | NIH | 8/18/2025 | $68,230 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL163585 | Impact of dilated cardiomyopathy mutations on cardiac myosin structure and function | 002 | 3 | NIH | 6/12/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 002 | 1 | NIH | 2/14/2025 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 001 | 1 | NIH | 11/15/2024 | $0 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 000 | 1 | NIH | 11/15/2024 | $35,909 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | F31EY037121 | Allosteric regulation of REDD1 as a therapeutic target for diabetic retinopathy | 003 | 1 | NIH | 6/18/2025 | $564 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35NS127217 | Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity | 001 | 4 | NIH | 9/13/2025 | $70,902 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R35NS127217 | Deciphering Early Stages of Polyomavirus CNS Pathogenesis and Immunity | 000 | 4 | NIH | 5/1/2025 | $896,585 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01AI162815 | Negative regulation of innate immune signaling pathways by the selective autophagy receptor TAX1BP1 | 001 | 5 | NIH | 6/6/2025 | $627,318 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01AA031470 | Vagal-hypothalamic modulation of alcohol intake | 000 | 2 | NIH | 7/8/2025 | $514,114 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01DK138060 | Diabetes RElated to Acute Pancreatitis and its Mechanisms: Metabolic Outcomes Using Novel CGM Metrics (DREAM-ON) | 000 | 2 | NIH | 4/30/2025 | $690,764 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01CA279357 | Integration of CSF Proteogenomics in the Diagnosis and Management of Diffuse Gliomas | 000 | 2 | NIH | 9/10/2025 | $614,772 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R01HL173869 | Multi-omic Characterization of COPD in Females | 000 | 2 | NIH | 7/17/2025 | $552,040 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | R21AI185281 | Autophagy and Hepatic Stellate cells activation | 000 | 2 | NIH | 4/8/2025 | $251,100 |
| 2025 | 2025 | PENNSYLVANIA STATE UNIVERSITY | 500 UNIVERSITY DRIVE | HERSHEY | PA | 17033-2391 | DAUPHIN | USA | T32GM149380 | Medical Scientist Training Program | 000 | 3 | NIH | 5/30/2025 | $584,450 |
|